Metformin, Empagliflozin, and Their Combination Modulate Ex-Vivo Macrophage Inflammatory Gene Expression

Type-2 Diabetes Mellitus is a complex, chronic illness characterized by persistent high blood glucose levels. Patients can be prescribed anti-diabetes drugs as single agents or in combination depending on the severity of their condition. Metformin and empagliflozin are two commonly prescribed anti-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Arefin, Adittya, Gage, Matthew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003317/
https://www.ncbi.nlm.nih.gov/pubmed/36902218
http://dx.doi.org/10.3390/ijms24054785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003317/
https://www.ncbi.nlm.nih.gov/pubmed/36902218
http://dx.doi.org/10.3390/ijms24054785

Ejemplares similares